ASHLEY MARTIN: Open Payments
NPI 1235534066 · COLCHESTER, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 22 payments from 8 companies in 2025. Trend: 2023 $454 · 2024 $278 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| ABBVIE INC. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: ARISTADA, COBENFY, CAPLYTA, REXULTI, VRAYLAR, FANAPT, INGREZZA, SPRAVATO.
Industry payments across IL — which companies pay providers there.
